Becton Dickinson and Co
Veridion Score
Composite trend over time
Why is BDX moving today?
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
BDX insider activity
Becton Dickinson and Co
3 insiders bought in the last 90 days
Net selling: -$538K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | 2026-06-01 | Polen Thomas E Jr | Insider | sell | $146.35 | 2,764 | 110,163 | $405K | SEC Form 4 |
| 2026-06-03 | 2026-06-01 | Polen Thomas E Jr | Insider | sell | $146.15 | 17,445 | 108,235 | $2.5M | SEC Form 4 |
| 2026-06-03 | 2026-06-01 | Polen Thomas E Jr | Insider | buy | $126.16 | 20,209 | 125,680 | $2.5M | SEC Form 4 |
| 2026-05-27 | 2026-05-26 | Feld Michael | Insider | sell | $147.35 | 75 | 21,084 | $11K | SEC Form 4 |
| 2026-05-08 | 2026-05-08 | Huffines Robert Luther | Insider | buy | $149.04 | 210 | 404 | $31K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 31 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moBDX contract awards, year to date.
Public federal awards linked to this ticker.
BDX lobbying filings, year to date.
Registered lobbying filings matched to Becton Dickinson and Co.